SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-000391
Filing Date
2021-01-06
Accepted
2021-01-06 20:19:57
Documents
2
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1481
2 EXHIBIT 24 brhc10018714_ex24.htm EX-24 5347
  Complete submission text file 0001140361-21-000391.txt   8328
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ROCKET PHARMACEUTICALS, INC. 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address
Garcia-Parada Carlos (Reporting) CIK: 0001839342 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 21512574